New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
As reported in Biopharma Dive, the FDA’s decision to strengthen its authority involving laboratory developed tests (LDTs) has drawn considerable objections from various healthcare groups. However, the Agency has held…